Apellis Pharmaceuticals recently announced post hoc analysis data of the GALE extension study. This new data is the result of ...

Parexel, a clinical research organizations providing the full range of Phase I to IV clinical development services, is joining forces with MyEyeDr., a vision healthcare organization, to refer its ...

New York, USA, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Gene Therapies In Ophthalmology Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | ...

Advanced imaging technologies like intraoperative OCT and heads-up displays enhance surgical precision and patient outcomes ...

Joseph M. Coney, MD, FACS, discusses the importance of diverse representation in clinical trials for the ongoing advancement of safe and effective treatments, and underscores the need for cultivating ...

Please provide your email address to receive an email when new articles are posted on . ROME — The total estimated costs from inherited retinal diseases in the United States amounts to $31.8 billion.

LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced a broad strategic ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — The American Academy of Ophthalmology announced the launch of the specialty’s first clinical data ...

Amakem Therapeutics, a clinical stage ophthalmology company, today presented top-line clinical results for its lead drug candidate, AMA0076 for the treatment of glaucoma, at the Ophthalmology ...